Company Filing History:
Years Active: 1991-1993
Title: Innovations by Geoffrey A Drane
Introduction
Geoffrey A Drane is a notable inventor based in Annandale, Australia. He has made significant contributions to the field of medical devices, particularly in the area of cardiac care. With a total of three patents to his name, Drane's work focuses on improving the functionality and effectiveness of implantable defibrillators.
Latest Patents
One of Drane's latest patents is titled "Apparatus and method for arrhythmia induction in arrhythmia control." This invention discloses an implantable medical device designed to provide therapy to patients with inadequately functioning hearts. The device utilizes a defibrillation electrode lead system to deliver therapy and includes a defibrillator that stores electrical charge for defibrillation therapy. The system is capable of selectively inducing arrhythmias in the patient's heart through a series of micro-shocks.
Another significant patent is "Reconfirmation prior to shock for implantable defibrillation." This invention involves a multiprogrammable, telemetric implantable defibrillator that features a high-energy shock system. The device includes a multi-programmable VVI bradycardia support system and requires two points of reconfirmation before delivering a shock to the patient. This ensures that the device operates safely and effectively.
Career Highlights
Throughout his career, Geoffrey A Drane has worked with several companies, including Telectronics Pacing Systems, Inc. and Telectronics N.V. His experience in these organizations has contributed to his expertise in developing advanced medical technologies.
Collaborations
Drane has collaborated with notable professionals in the field, including Steven M Weiss and Norma L Gilli. These collaborations have likely enhanced the innovation and effectiveness of his inventions.
Conclusion
Geoffrey A Drane's contributions to medical device innovation, particularly in cardiac care, have made a significant impact on patient treatment options. His patents reflect a commitment to improving the safety and efficacy of defibrillation therapy.